相关实验视频

Updated: Jul 3, 2025

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

在质母细胞瘤中,缺氧诱导的PRMT2成

Feng Dong¹, Xiaoyu Sun², Jiacheng Su²

¹State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Medical Epigenetics, School of Biomedical Engineering & Technology, Tianjin Medical University, Tianjin 300070, China; Department of Cell Biology, Tianjin Medical University, Qixiangtai Road 22, Tianjin 300070, China.

Cellular signalling

|February 10, 2024

概括

低氧诱导因素 (HIFs) 在低氧条件下激活蛋白质氨酸甲基转移酶2 (PRMT2). PRMT2通过激活缺氧诱导的基因来驱动质母细胞瘤的进展,使其成为潜在的治疗点.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

低氧诱导的转录因子 (HIF) 调节细胞对低氧的反应.
在HIF驱动转录的精确媒介仍然不完全理解.
蛋白质氨酸甲基转移酶2 (PRMT2) 是一种与基因素甲基化和转录激活相关的联合激活剂.

研究的目的:

研究PRMT2在缺氧诱导的转录中的作用.
阐明HIF1α和PRMT2.2之间的监管关系.
评估在质母细胞瘤中准PRMT2的治疗潜力.

主要方法:

在低氧条件下研究了HIF1α对PRMT2的激活.
评估了PRMT2对缺氧诱导的基因转录的要求.
在异种移植模型中评估了PRMT2抑制对质母细胞细胞迁移,瘤进展和化学敏感性的影响.
分析了临床质瘤样本,以查看PRMT2,HIF1α和患者预后之间的相关性.

主要成果:

在低氧状态下,PRMT2由HIF1α激活.
PRMT2及其H3R8me2a活性对于低氧诱导基因的一个子集至关重要.
通过PRMT2无活化,减少了质母细胞细胞迁移,瘤生长,并改善了化学敏感性.
临床数据显示,PRMT2/HIF1α水平与预后不佳之间存在相关性.

结论:

HIF1α诱导PRMT2,这对于激活缺氧相关的转录程序至关重要.
在质母细胞瘤中,PRMT2驱动恶性进展.
向PRMT2为质母细胞瘤提供了一个有前途的治疗策略.

关键词:

质母细胞瘤 (glioblastoma) 是一个里斯阿尔金因甲基化氧气过低是因为缺氧.蛋白质氨酸甲基转移酶2的蛋白质氨酸转录翻译翻译

更多相关视频

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...